CIL, the world leader in the separation of ¹⁸O and ¹³C isotopes for medical applications and the world's largest supplier of stable isotope labeled research compounds, is pleased to announce that the expansion of CIL's ¹⁸O separation facility, completed at the end of 2002, has increased CIL's production capacity of ¹⁸O to over 250kg per year.

With our breadth of experience and expertise in GMP/FDA medical products, CIL is very responsive to the growing needs of the PET community for consistently high quality product delivered on time at a fair price. CIL has made a significant investment in the future of ¹⁸O applications for both PET and metabolism studies of energy expenditure.